Literature DB >> 16945998

Isolation and characterization of a stem cell population from adult human liver.

Maria Beatriz Herrera1, Stefania Bruno, Stefano Buttiglieri, Ciro Tetta, Stefano Gatti, Maria Chiara Deregibus, Benedetta Bussolati, Giovanni Camussi.   

Abstract

Several studies suggested the presence of stem cells in the adult normal human liver; however, a population with stem cell properties has not yet been isolated. The purpose of the present study was to identify and characterize progenitor cells in normal adult human liver. By stringent conditions of liver cell cultures, we isolated and characterized a population of human liver stem cells (HLSCs). HLSCs expressed the mesenchymal stem cell markers CD29, CD73, CD44, and CD90 but not the hematopoietic stem cell markers CD34, CD45, CD117, and CD133. HLSCs were also positive for vimentin and nestin, a stem cell marker. The absence of staining for cytokeratin-19, CD117, and CD34 indicated that HLSCs were not oval stem cells. In addition, HLSCs expressed albumin, alpha-fetoprotein, and in a small percentage of cells, cytokeratin-8 and cytokeratin-18, indicating a partial commitment to hepatic cells. HLSCs differentiated in mature hepatocytes when cultured in the presence of hepatocyte growth factor and fibroblast growth factor 4, as indicated by the expression of functional cytochrome P450, albumin, and urea production. Under this condition, HLSCs downregulated alpha-fetoprotein and expressed cytokeratin-8 and cytokeratin-18. HLSCs were also able to undergo osteogenic and endothelial differentiation when cultured in the appropriated differentiation media, but they did not undergo lipogenic differentiation. Moreover, HLSCs differentiated in insulin-producing islet-like structures. In vivo, HLSCs contributed to regeneration of the liver parenchyma in severe-combined immunodeficient mice. In conclusion, we here identified a pluripotent progenitor population in adult human liver that could provide a basis for cell therapy strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16945998     DOI: 10.1634/stemcells.2006-0114

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  140 in total

1.  Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Authors:  Vera S Donnenberg; Albert D Donnenberg; Ludovic Zimmerlin; Rodney J Landreneau; Rohit Bhargava; Ryan A Wetzel; Per Basse; Adam M Brufsky
Journal:  Cytometry B Clin Cytom       Date:  2010-04-30       Impact factor: 3.058

2.  Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent.

Authors:  Paula Dore-Duffy; Afroza Mehedi; Xueqian Wang; Michael Bradley; Richard Trotter; Alexander Gow
Journal:  Microvasc Res       Date:  2011-04-15       Impact factor: 3.514

Review 3.  Human Liver Progenitor Cells for Liver Repair.

Authors:  Catherine A Lombard; Julie Prigent; Etienne M Sokal
Journal:  Cell Med       Date:  2013-04-29

Review 4.  Biomaterials approach to expand and direct differentiation of stem cells.

Authors:  Chou Chai; Kam W Leong
Journal:  Mol Ther       Date:  2007-01-30       Impact factor: 11.454

5.  Enrichment of a bipotent hepatic progenitor cell from naïve adult liver tissue.

Authors:  Natasha Wright; Lisa Samuelson; Maggie H Walkup; Prakash Chandrasekaran; David A Gerber
Journal:  Biochem Biophys Res Commun       Date:  2007-12-04       Impact factor: 3.575

Review 6.  Stem cells for liver tissue repair: current knowledge and perspectives.

Authors:  Philippe A Lysy; David Campard; Françoise Smets; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

7.  Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells.

Authors:  Ellen P Brennan; Xiao-Han Tang; Ann M Stewart-Akers; Lorraine J Gudas; Stephen F Badylak
Journal:  J Tissue Eng Regen Med       Date:  2008-12       Impact factor: 3.963

Review 8.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.

Authors:  Philippe-A Lysy; Mustapha Najimi; Xavier Stephenne; Annick Bourgois; Francoise Smets; Etienne-M Sokal
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

9.  The identification of stem cells in human liver diseases and hepatocellular carcinoma.

Authors:  Joan Oliva; Barbara A French; X Qing; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-01-18       Impact factor: 3.362

Review 10.  Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.

Authors:  Gurpreet Kaur; Praveen Sharma; Nilambra Dogra; Sandeep Singh
Journal:  Curr Treat Options Oncol       Date:  2018-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.